StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
1321 – 1340 of 1357
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Cripto Selectively Expands a Distinct Population of Hematopoietic Stem Cells Expressing the Cell Surface Receptor GRP78 and Strongly Induces An Immature Phenotype In Vivo After Ex Vivo Culture
(
- Contribution to journal › Published meeting abstract
-
Mark
Cripto Selectively Expands a Distinct Population Of Hematopoietic Stem Cells Expressing Cell Surface Receptor GRP78
2010) 39th Annual Scientific Meeting of the ISEH - Society-for-Hematology-and-Stem-Cells In Experimental Hematology 38(9). p.038-038(
- Contribution to journal › Published meeting abstract
-
Mark
Second-Generation BCR-ABL Kinase Inhibitors in CML
(
- Contribution to journal › Letter
-
Mark
Characterization of human ESC cell-derived MSC compared to bone marrow-derived MSC indicates that hES-MSC might be a possible alternative and unlimited cell source for clinical off-the-shelf MSC therapies
2010) 36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting In Bone Marrow Transplantation 45(Suppl.2). p.326-326(
- Contribution to journal › Published meeting abstract
-
Mark
Islet {beta}-cell-specific MafA transcription requires the 5'-flanking conserved Region 3 control domain.
(
- Contribution to journal › Article
-
Mark
Successful Treatment of Metachromatic Leukodystrophy Using Bone Marrow Transplantation of HoxB4 Overexpressing Cells
(
- Contribution to journal › Article
-
Mark
The Proportion of Ph+CD34(+)CD38(neg) Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI Therapy Data From a Randomized Phase II NordCML006 Study
(
- Contribution to journal › Published meeting abstract
-
Mark
The Success Story of Targeted Therapy In Chronic Myeloid Leukemia A Population Based Study of 3,173 Patients Diagnosed In Sweden 1973-2008
(
- Contribution to journal › Published meeting abstract
-
Mark
Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion
(
- Contribution to journal › Article
-
Mark
Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice
(
- Contribution to journal › Article
-
Mark
High Levels of the Adhesion Molecule CD44 on Leukemic Cells Generate Acute Myeloid Leukemia Relapse After Withdrawal of the Initial Transforming Event
(
- Contribution to journal › Published meeting abstract
-
Mark
SMAD4 Sequestrates HOXA9 to Protect Hematopoietic Stem Cells Against Leukemia Transformation
(
- Contribution to journal › Published meeting abstract
-
Mark
Identification of a NK/T cell restricted progenitor in adult bone marrow contributing to bone marrow and thymic-dependent NK cells.
(
- Contribution to journal › Article
-
Mark
A Novel Immunohistochemical Sequential Multi Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis
(
- Contribution to journal › Published meeting abstract
-
Mark
KAP1 controls endogenous retroviruses in embryonic stem cells
(
- Contribution to journal › Letter
-
Mark
Down-regulation of the antigen processing machinery components in glioblastoma
(
- Contribution to journal › Published meeting abstract
-
Mark
Tapasin discriminates stable from unstable peptide-HLA-I complexes
(
- Contribution to journal › Published meeting abstract
-
Mark
The N-terminal part of tapasin facilitates folding of major histocompatibility complex class I
(
- Contribution to journal › Published meeting abstract
-
Mark
Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis
(
- Contribution to journal › Article
-
Mark
Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita
(
- Contribution to journal › Article